Living With Acute Myeloid Leukemia (AML)

Acute myeloid leukemia, or AML, is a fast-growing cancer of the blood and bone marrow. Unlike some blood cancers, AML usually needs treatment quickly, and one subtype, acute promyelocytic leukaemia, is a genuine emergency treated on its own pathway. Day-to-day life with AML often means time in the hospital, close monitoring, and real attention to infection risk, especially in the weeks right after diagnosis.

The first phase is called induction. Its goal is to clear leukemia cells from your blood and bone marrow as quickly as possible. The second phase, consolidation, follows once you are in remission. It targets any remaining leukemia cells that could cause a relapse later. Together, these phases can mean weeks in the hospital, since your blood counts drop very low during this time and need close medical support.

That is the intensive route, and it is not everyone's. Acute promyelocytic leukaemia is treated on a separate pathway that looks very different. People who are older or less fit, or whose molecular results point elsewhere, are often given lower-intensity drug treatment that can be largely outpatient. Whether a stem cell transplant is planned changes the shape again. Ask your leukaemia team which route you are on before you make plans around it.

AML itself crowds out healthy blood cells. Treatment lowers your counts further, on purpose, to kill leukemia cells. This combination leaves you with very little natural infection defense for a stretch of time. Antibiotics and antifungal medicines are often used during this period to prevent or treat infections before they become dangerous.

Call your care team immediately for a fever of 100.4°F or higher. During intensive AML treatment, this is treated as a true emergency, not something to wait out at home. If you are in the hospital, tell your nurse right away; if you are at home, call your team or go to the emergency room.

Red blood cell and platelet transfusions are a routine, expected part of AML treatment where they are needed, not a sign that something has gone wrong. Your team gives them when your counts and your symptoms call for it, so how many you need varies widely. They replace blood cells destroyed by the leukemia and by chemotherapy, while your bone marrow recovers. Many people need multiple transfusions over the course of treatment.

After treatment, your team continues checking your blood and bone marrow regularly, even once you are in remission. These tests show whether your counts stay normal, or whether leukemia cells are starting to come back. This kind of follow-up testing continues for a period after treatment ends, since AML can relapse even after a good initial response.

Many people with AML spend real stretches of time in the hospital. This is especially true during induction. It can feel disorienting, on top of an already frightening diagnosis. Ask your care team what a typical stay looks like. This helps you and your family plan around work, childcare, and other responsibilities. Bring comfort items from home if your unit allows it. Your own pillow, photos, or music can make a hospital room feel less clinical.

A diagnosis this intense affects the whole household, not just the person with AML. Ask your hospital's social worker about support for caregivers and children at home. Ask about practical help too, like meals, transportation, or work leave. Many cancer centers also connect patients with peer support. That means other people who have been through AML treatment, who can speak to what it is actually like.

Call your care team immediately for a fever of 100.4°F or higher, new bleeding or bruising, shortness of breath, or a feeling of severe fatigue that comes on quickly. These can be signs of infection, low blood counts, or a change in your leukemia that needs urgent attention.

Ask what to expect during the induction and consolidation phases, including how long each typically lasts. Ask how your team will manage infection risk while your counts are low. Ask how often you will need blood tests once you are in remission, and what would prompt a bone marrow test to check for relapse.

• National Cancer Institute — Acute Myeloid Leukemia Treatment (PDQ).
• National Cancer Institute — Infections in People with Cancer.